Transfusion associated graft-versus-host disease (TA-GVHD) in an immunocompetent patient following orthopedic surgery

Marmara Medical Journal

Volumn 19, Issue 1, 2006, Pages 36-40

  Batirel, Ayşe ^a,c   Özer, Serdar ^a   Gençer, Serap ^a   Şeker, Mesut ^a   Çetiner, Mustafa ^b   Egegül, Aylin ^a   Karadayi, Nimet ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c Enfeksiyon Hastaliklari ve Klinik Mikrobiyoloji Klini i   (Turkey)

Author keywords

Immunocompetent; Rash; Transfusion associated graft versus host disease

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; FLUCONAZOLE; MEROPENEM; PREDNISOLONE;

ADULT; ANAMNESIS; ARTICLE; BLOOD SMEAR; BONE MARROW APLASIA; CASE REPORT; CELLULAR IMMUNITY; CLINICAL FEATURE; FEVER; GRAFT VERSUS HOST REACTION; HIP OSTEOARTHRITIS; HISTOCOMPATIBILITY; HISTOPATHOLOGY; HUMAN; INFECTION; LIVER DYSFUNCTION; LYMPHOID CELL; MALE; PANCYTOPENIA; RASH;

EID: 34249080830     PISSN: 10191941     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. th Ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. Volume 1: 862-863.
2. th Ed. Philadelphia, 1997: 240-244.
3. rd ed. Philadelphia: Lippincott Williams & Wilkins, 2002: 852-864.
4. Brubaker DB. Human posttransfusion graft versus host disease. Vox Sang 1983; 45: 401-420.
5. Anderson KC, Weinstein HJ. Transfusion-associated graft versus host disease. N Engl J Med 1990; 323: 315-321.
6. nd degree relative, and a survey of predisposing factors. Transfusion 1993; 33: 742-750.
7. McMilin KD, Johnson RL. HLA homozygosity and the risk of related-donor transfusion-associated graft versus host disease. Transfus Med Rev 1993; 7: 37-41.
8. Schroeder ML. Transfusion-associated graft versus host disease. Br J Haematol 2002; 117: 275-287.